Lamotrigine injection - CyDex
Latest Information Update: 15 Sep 2014
At a glance
- Originator CyDex Pharmaceuticals
- Class Antiepileptic drugs; Small molecules; Triazines
- Mechanism of Action Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Seizures
Most Recent Events
- 09 Sep 2014 Preclinical trials in Seizures in USA (IV)
- 09 Sep 2014 Preclinical trials in Seizures in USA (IM)